SCHEMBL20559620

SCHEMBL20559620

Cc1nc(Nc2nc(N3CCC(O)CC3)cc(N3CCC(O)CC3)n2)sc1C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 6/20 0.76
▸ ALDH1A1 P00352 5/20 0.46
▸ HPGD P15428 2/20 0.46
▸ IKBKB O14920 2/20 0.44
▸ CCNT1 O60563 1/20 0.44
▸ CDK4 P11802 1/20 0.44
▸ CCND1 P24385 1/20 0.44
▸ CDK9 P50750 1/20 0.44
▸ CDK6 Q00534 1/20 0.44
▸ CDK11A Q9UQ88 1/20 0.44
▸ TSHR P16473 1/20 0.43
▸ MAPT P10636 2/20 0.41
▸ LMNA P02545 2/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ PTGER4 P35408 2/20 0.41
▸ FGFR1 P11362 1/20 0.41
▸ KDM4E B2RXH2 1/20 0.40
▸ CHUK O15111 1/20 0.39
▸ NTRK1 P04629 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27950966 0.95 PDE5A (0.69) PDE5AALDH1A1HPGDIKBKBCCNT1
SCHEMBL290592 0.92 PDE5A (0.66) PDE5AALDH1A1HPGDIKBKBCCNT1
SCHEMBL291123 0.92 PDE5A (0.68) PDE5AALDH1A1HPGDIKBKBCCNT1
SCHEMBL27937571 0.90 PDE5A (0.64) PDE5AALDH1A1HPGDIKBKBCCNT1
SCHEMBL27950937 0.87 PDE5A (0.60) PDE5AALDH1A1HPGDIKBKBCCNT1
SCHEMBL27937575 0.87 PDE5A (0.60) PDE5AALDH1A1HPGDIKBKBCCNT1
SCHEMBL27950936 0.87 PDE5A (0.59) PDE5AALDH1A1HPGDIKBKBCCNT1
SCHEMBL290844 0.86 PDE5A (1.00) PDE5AALDH1A1HPGDMAPTLMNA
SCHEMBL26647638 0.86 PDE5A (0.57) PDE5AALDH1A1HPGDCCNT1CDK4
SCHEMBL26647596 0.86 PDE5A (0.58) PDE5AALDH1A1HPGDIKBKBCCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2846805-B1 TREATMENT OF ADDICTION AND IMPULSE-CONTROL DISORDERS USING PDE7 INHIBITORS OMEROS CORP (US) 2018-11-21 — — EP disclosed
Send feedback